Latest: 5 expert webinars you won't want to miss
Latest: Abbott's Panbio Rapid Antigen Test gains CE Mark for use on children
Latest: Accelerating microbiome research: The new reference material improving data quality
Latest: What the UK’s FSA wants to see on submissions for CBD product authorization
Latest: Promoting more sustainable mining practices with Malvern Panalytical’s water monitoring...
Latest: 5 expert webinars coming up this week
Latest: New Cypher VRS1250 video-rate atomic force microscope enables true video-rate imaging at...
Accelerating microbiome research: The new reference material improving data quality
‘Effective communication enables you to stand on other people's shoulders and see much further'
Biotinylated heparan sulfate antibodies
New Rigaku handheld LIBS analyzer provides high-performance metal alloy analysis
Access your free cancer and immunology resources ahead of the virtual summit
5 expert webinars you won't want to miss
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
The essential guide to ELISA automation
Nexsa G2 Surface Analysis System: Fast travel to definitive surface analysis
Magnis NGS Prep System brochure
Agilent NovoCyte Advanteon flow cytometer brochure
Agilent Seahorse XF live-cell metabolism solutions for cancer research
DNA/RNA Purification and Analysis
Pre-Clinical and Clinical Automation
Cell Counting Technology
Cell Analysis Microscopy Equipment
Virtual Analytical Summit
SelectScience Virtual Summit...
11 May 21 - 12 May 21
21 May 21 - 25 May 21
07 Jun 21 - 11 Jun 21
22 Jun 21 - 23 Jun 21
SLAS Europe 2021
22 Jun 21 - 25 Jun 21
LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
As regulatory pressure increases on pharmaceutical companies to investigate the potential interaction between a dosage form and the components of the primary closure and transfer system employed, leachables and extractables studies are be... Read more...
LGC is highly experienced in the application of a broad range of material characterisation techniques and packages and has the knowledge to support your product development from discovery to product registration and beyond. Read more...
Within the pharmaceutical sector, there is an increasing regulatory requirement for the characterisation and counting of visible and sub-visible foreign particles in pharmaceutical products from a safety, quality and efficacy perspective. Read more...
Bringing together Axolabs, Biosearch Technologies and the broader analytical and bioanalytical capabilities available across the company, LGC has a unique heritage and expertise in the development oligonucleotide therapeutics and nucleic ... Read more...
ProBioGen holds a manufacturing authorization for GMP (Good manufacturing practice) compliant manufacturing and batch release of biotechnological drug substances and fulfills all present regulatory requirements by EMA and FDA.
GMP Man... Read more...
Ready 4 Action, proprietary feasibility assessment, sets the cornerstone of a cost-effective product development plan.
Ready 4 Action is the four-step process used to evaluate the viability of proposed drug products. This important to... Read more...
Camargo ensures the appropriate regulatory requirements are met every step of the way, streamlining your drug development process all the way to approval. Ready to guide you through the preclinical stage of drug development, Camargo pr... Read more...
Superior Regulatory Service Helps Transform Your Clinical Trials.
Strong regulatory strategies are pivotal in getting products to market. While many countries’ drug regulations are similar, there are still significant differences. The... Read more...